explore -WSS

explore

author：knowledge 2025-10-02 00:28:29 - browse：589

Since the early days of the pandemic, long Covid has haunted us: Even a mild acute infection might leave you with life-altering consequences. And for many, that has, sadly, turned out to be the case. While research suggests long Covid rates are falling, it still affects millions. In June 2023, 6% of Americans reported experiencing long Covid.

But what if long Covid isn’t the right way to think about what they are going through?

On this episode of the First Opinion Podcast, I spoke with Steven Phillips and Michelle A. Williams, authors of a recent First Opinion essay titled, “Long Covid is a new name for an old syndrome.” Steven is a Global Virus Network board member and vice president for science and strategy at the COVID Collaborative; Michelle is the former dean and current Joan and Julius Jacobson professor of epidemiology and public health at the Harvard T.H. Chan School of Public Health.

“Michelle and I have come up with basically a new paradigm that says long Covid is really an old disease, and the more you do deep dives into the history of chronic fatigue syndrome and post-infectious fatigue syndromes, the more you realize that not only are there similarities, but the level of congruence between the two is strikingly high,” Steven said.

The purpose of this new paradigm is to “break the logjam” of the current long Covid discourse and “to try to provide a framework whereby people would think about long Covid in a different way in a way that would be more productive,” Michelle told me.

We discussed the history of post-infectious disease syndrome, what rethinking long Covid might mean for research, and the ways the health care system fails chronically ill patients.

Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, Google Play, or wherever you get your podcasts.

Previous article： Activists slam private health insurers over coverage restrictions
Next article： Goldman Sachs launches $650M fund for life science investments

WSS

4th of July breaks record for highest global temperature ever measured

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

U.K. sequencing study surfaces new findings about tumor DNA

4th of July breaks record for highest global temperature ever measured

Duchenne patients, backed by ‘dark money’ group, to debate drug prices

Why is France rioting? What to know about the fatal police shooting of Nahel M

entertainment

explore

hotspot

Dobbs anniversary: the lost opportunity of abortion as health care

Chronically ill young patients struggle to find fertility info

Moonlake's readout produced a cash windfall. Risks remain

Can food be medicine? And other questions about a new push

Malaria cases in Florida and Texas: Here’s what you need to know

Videos point to link between seizures and unexplained toddler deaths

Apple is now the first public company to be valued at $3 trillion

Van's Gluten Free Original Waffles recalled for possible wheat allergen

In age of alternative facts, a scholarly course on calling out crap

A single drug, study failures leave Anavex with nothing but cash

hotspot

7 people shot in DC, police say

A single drug, study failures leave Anavex with nothing but cash

Listen: Biogen's messy board & Laronde's data problem

New weight loss drugs work. But how can they best be used?

Videos point to link between seizures and unexplained toddler deaths

Goldman Sachs launches $650M fund for life science investments

hotspot

explore

focus

Wikipedia